ESMO 2018 Press Releases

Viewing 1-14 of 14 articles

2018 ESMO Immuno-Oncology Award Goes to Cornelis Melief

Local Radiotherapy Improves Survival in Metastatic Prostate Cancer with Low Disease Burden

Avelumab Plus Axitinib Significantly Improve Progression-Free Survival in Untreated Renal Cell Carcinoma

ESMO 2018: Nivolumab in Combination with Iipilimumab Shows Promising Results in Patients with Advanced Form of Bladder Cancer

Huge Variations Between Countries in Time for Reimbursement Decisions on New Cancer Drugs

ESMO Women for Oncology Forum Focuses on Power Sharing to Foster Gender Equality

Financial Impacts of Cancer Found to Intensify Disease Burden Among German Patients

Trust in Non-conventional Therapies by Cancer Patients Not Matched with Proper Awareness About Their Risks

Janssen to Showcase Robust Oncology Portfolio at ESMO 2018 Congress

Cabozantinib to Be Featured in 13 Presentations at ESMO 2018 Congress

Bayer to Showcase Latest Oncology Research at ESMO 2018 Congress

Merck’s Broad Oncology Pipeline to Be Highlighted at ESMO 2018 Congress

Targeted Drugs for Advanced Cancer Move From Specialist Units to Community Setting

Clovis Oncology to Highlight Results from Rucaparib TRITON Prostate Program at ESMO 2018 Congress